1. Home
  2. List
Reference Patent

Reference - List

  • 14 Hits
  • Search Condition : Filter (MeSH = Osteoclasts)
Species Resource Title
General Microbes , Human and Animal Cells JCM6328 , MC3T3-E1(RCB1126) Possible roles of short-chain fatty acids produced by oral bacteria in the development of alveolar osteitis.
Human and Animal Cells MC3T3-E1(RCB1126) (S)-Equol Is More Effective than (R)-Equol in Inhibiting Osteoclast Formation and Enhancing Osteoclast Apoptosis, and Reduces Estrogen Deficiency-Induced Bone Loss in Mice.
Human and Animal Cells RAW 264(RCB0535) Mechanoregulation of Osteoclastogenesis-Inducing Potentials of Fibrosarcoma Cell Line by Substrate Stiffness.
Zebrafish gSAGFF202A , Tg(mmp9:egfp)tyt206 , HGn39D , hspGFFDMC13F , UAS:EGFP , UAS:RFP Remodeling of the hyomandibular skeleton and facial nerve positioning during embryonic and postembryonic development of teleost fish.
Human and Animal Cells RAW 264(RCB0535) Porphyromonas gingivalis Fimbriae Induce Osteoclastogenesis via Toll-like Receptors in RAW264 Cells.
Human and Animal Cells 293T(RCB2202) The role of CDK8 in mesenchymal stem cells in controlling osteoclastogenesis and bone homeostasis.
Human and Animal Cells MC3T3-E1(RCB1126) Effect of aging on bone metabolism: the involvement of complement C1q.
Human and Animal Cells MH7A(RCB1512) Metformin repositioning in rheumatoid arthritis.
Human and Animal Cells MC3T3-E1(RCB1126) Punicalagin ameliorates wear-particle-induced inflammatory bone destruction by bi-directional regulation of osteoblastic formation and osteoclastic resorption.
Human and Animal Cells C2C12(RCB0987) , MC3T3-E1(RCB1126) Bovine lactoferrin enhances osteogenesis through Smad2/3 and p38 MAPK activation.
Medaka mpz-EGFP (TG1358) , Tg(fli1:DsRed) (TG1361) Myelination during fracture healing in vivo in myelin protein zero (p0) transgenic medaka line.
Human and Animal Cells UV♀2(RCB1994) Exosomal transfer of osteoclast-derived miRNAs to chondrocytes contributes to osteoarthritis progression.
Human and Animal Cells MG6(RCB2403) Therapeutic Effects of Systemic Administration of the Novel RANKL-Modified Peptide, MHP1, for Ischemic Stroke in Mice.
Human and Animal Cells RAW 264(RCB0535) Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss.